Boston Children's Hospital is a pediatric academic medical center that embedded an enterprise ChatGPT layer across its clinical, research, and administrative operations and used it to diagnose more than 40 rare conditions that had previously gone unresolved.
A case study published by OpenAI on May 29, 2026 describes how Boston Children's Hospital moved beyond isolated AI pilots to build a shared internal ChatGPT environment used by clinical teams, researchers, supply chain staff, billing departments, and surgical scheduling coordinators. More than a third of the hospital's employees now use the platform daily. Boston Children's Hospital attributed roughly 60,000 hours in time savings and more than $7 million in redeployed labor to over 50 automations; those figures are self-reported by the institution and have not been independently verified.
The clinical centerpiece is what Boston Children's Hospital calls a "co-pilot geneticist": a system that combines a patient's genetic data, phenotypic profile, and a real-time sweep of global medical literature to generate diagnostic hypotheses for cases that resisted standard workups. Chief Innovation Officer John Brownstein said the tool has produced more than 40 diagnoses in previously unsolved rare disease cases and has surfaced new gene targets and candidate therapeutic pathways. "We combine genetic information, phenotypic information, literature search, and the reasoning of AI to deliver diagnoses to families that were once left without any answers," Brownstein said in the OpenAI case study.
Boston Children's Hospital operates across more than 40 specialties and handles close to 1 million outpatient visits annually, so even modest per-encounter time savings aggregate quickly at that scale. The ChatGPT layer also compressed internal development cycles from months to days, Brownstein said, by providing a shared foundation where new tools could be built against existing governance and safety-monitoring infrastructure rather than starting from scratch.
OpenAI positions the Boston Children's Hospital deployment as a template for health systems weighing enterprise AI adoption, but how well the co-pilot geneticist's performance generalizes to institutions with less annotated genetic data and fewer in-house AI engineering resources remains the open question for potential adopters. Continued collaboration with OpenAI on model refinement is described as a next priority.
